Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 751 clinical trials
Ethosuximide and Pentoxifylline in the Treatment of Abdominal Pain Related to Irritable Bowel Syndrome

Ethosuximide and pentoxifylline in the treatment of abdominal pain related to irritable bowel syndrome

mebeverine
irritable bowel syndrome
abdominal pain
stomach pain
  • 0 views
  • 16 Feb, 2024
  • 1 location
The Effect of a Low FODMAP Diet in Irritable Bowel Syndrome Patients

During the screening phase of two weeks, baseline data regarding psychological, nutritional, microbial, and genetics will be collected. Predictors of treatment response (a 50-point drop on the IBS-severity scoring system (IBS-SSS) during the strict FODMAP exclusion phase of 6 weeks) will be studied with linear mixed models.

fodmap diet
irritable bowel syndrome
  • 0 views
  • 16 Feb, 2024
  • 1 location
GutMe!: IBS and Collagen Protein Powder an Interventional Study

In this study we would like to understand how or if a food-based supplement affects gut symptoms such as bloating, stomach cramps and irregular bowel habits. Through using a digital symptom tracking app for a few weeks, you may just learn more about exactly what is triggering your symptoms!

bloating
spasm
gut symptoms
  • 0 views
  • 16 Feb, 2024
  • 1 location
Magnetic Resonance Imaging of the Brain and Stomach in Healthy Volunteers and Gastroparesis

The study is to lay the groundwork for non invasive imaging of the GI tract and the brain gut interaction

gastroparesis
epigastric pain
nausea
early satiety
regurgitation
  • 0 views
  • 16 Feb, 2024
  • 1 location
Inflammatory Bowel Disease (IBD) Research Registry

Information obtained from the Inflammatory Bowel Disease Registry will allow a better classification of disease and factors that influence the natural course of disease; which may lead to a better understanding of the pathogenesis of IBD and may permit the development of better therapies and the potential for preventive therapies.

  • 0 views
  • 16 Feb, 2024
  • 1 location
Percentage Visualized Mucosa as a Marker for the Quality of Colonoscopy

Primary hypothesis: The percentage of mucosa visualized during the withdrawal of a colonoscopy with reference to the position in the colon by means of the scope-guide is an appropriate parameter for assessment of the quality of colonoscopy and correlates with the probability of the detection of adenomas. Secondary hypothesis: The …

adenoma
bowel preparation
complete colonoscopy
  • 0 views
  • 16 Feb, 2024
  • 1 location
The Impact of COVID-19 on the Health Care Utilization of Inflammatory Bowel Disease

During a pandemic, patients with IBD may postpone hospital visits due to concerns about infection with COVID-19, and if they cannot continue drug treatment, there is a concern about the flare up IBD disease activity.

covid-19
  • 0 views
  • 16 Feb, 2024
  • 1 location
PROtocol of Metabolic and Cryptogenic livEr Disease regisTry for intEgration of Omic Studies

The main aim of the study is to set up an observational cohort with NAFLD (Non-alcoholic fatty liver disease) at different stage of disease (from simple steatosis to cirrhosis and/or HCC-Hepatocellular carcinoma) and for comparative purpose a cohort of subjects with diabetes and/or obesity and/or other risk factors (i.e. psoriasis, …

steatosis
fatty liver
non-alcoholic fatty liver
hepatitis c
psoriasis
  • 0 views
  • 16 Feb, 2024
  • 1 location
A Non-Interventional Pilot Study to Explore the Role of Gut Flora in IBS

This study seeks to correlate microbiome sequencing data with information provided by patients and their medical records.

  • 0 views
  • 16 Feb, 2024
  • 1 location
Impact of Isolation in Patients With IBD During the COVID-19 Crisis

The coronavirus pandemic has changed healthcare dramatically in a short time. Individuals with chronic illnesses and services for them have had to adapt and change to deal with requirements for shielding and social isolation to reduce infection risk and management of medication investigation and ongoing review. It is increasingly recognised …

enteropathy
anxiety
chronic disease
inflammatory bowel disease
covid-19
  • 0 views
  • 05 Aug, 2020